Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AMIDEX35 Israel Fund Class A (AMDAX)

Net Asset Value
1 Day
Overall Morningstar Rating
Miscellaneous region
Style or Category
Sales Expenses
Expense Ratio
Morningstar Risk Rating™
Investment Objective The investment seeks long-term growth of capital. The fund will invest at least 95% of its net assets in the common stocks of the companies comprising the AMIDEX35™ Index, in approximately the same percentages as those companies are included in the index or until the fund's net assets reach $25 million, the Adviser may invest fund assets in a representative sample of index securities and other permissible securities. The AMIDEX35™ Index is an unmanaged index consisting of the 35 largest publicly traded Israeli companies, as measured by market capitalization. It is non-diversified.


1 month-1.63% 3 years+1.82%
3 months+1.58% 5 years-4.16%
1 year-16.77% Since inception+0.58%
Data through --

Peer Comparisonvs. Miscellaneous region

Performance 5-yr return-4.16%+3.00%
Expense ratio3.38%1.78%
Risk 5 year sharpe ratio-0.26--
Net assets$10.0M$192.7M
Average market cap$6.2B$22.7B
Average P/E18.414.4
Portfolio turnover5%5%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyAMIDEX
Fund manager & tenureGadi Beer / 12 Years
Minimal initial investment$500.00
Minimum IRA investment$500.00


International stock66.46%
U.S. stock30.86%
Fixed income0.00%
Top 5 Sectors
Portfolio weighting
Industrial materials 27.12%
Healthcare 24.31%
Telecommunication 13.32%
Consumer goods 4.11%
Hardware 2.63%
Top 10 Holdings
Portfolio weighting
TEVA Teva Pharmaceutical10.82%
PRGO Perrigo Company PLC9.66%
CHKP Check Point Software Technologies Ltd7.53%
TARO Taro Pharmaceutical Industries Ltd6.33%
DOX Amdocs Ltd4.57%
-- 3.84%
-- 3.45%
OPK OPKO Health Inc3.31%
-- 3.16%
-- 3.11%

Partner Offers